These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 6763406

  • 1. Mutagenic properties of allylic and alpha, beta-unsaturated compounds: consideration of alkylating mechanisms.
    Eder E, Henschler D, Neudecker T.
    Xenobiotica; 1982 Dec; 12(12):831-48. PubMed ID: 6763406
    [Abstract] [Full Text] [Related]

  • 2. Structure-activity relationships of alpha, beta-unsaturated carbonylic compounds.
    Henschler D, Eder E.
    IARC Sci Publ; 1986 Dec; (70):197-205. PubMed ID: 3539786
    [Abstract] [Full Text] [Related]

  • 3. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD.
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [Abstract] [Full Text] [Related]

  • 4. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H, Seidel A, Bochnitschek W, Marquardt H, Marquardt H, Hodgson RM, Grover PL, Oesch F.
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [Abstract] [Full Text] [Related]

  • 5. Mutagenicity of chloroolefins in the Salmonella/mammalian microsome test. III. Metabolic activation of the allylic chloropropenes allyl chloride, 1,3-dichloropropene, 2,3-dichloro-1-propene, 1,2,3-trichloropropene, 1,1,2,3-tetrachloro-2-propene and hexachloropropene by S9 mix via two different metabolic pathways.
    Neudecker T, Henschler D.
    Mutat Res; 1986 Sep; 170(1-2):1-9. PubMed ID: 3515164
    [Abstract] [Full Text] [Related]

  • 6. Correlation of alkylating and mutagenic activities of allyl and allylic compounds: standard alkylation test vs. kinetic investigation.
    Eder E, Neudecker T, Lutz D, Henschler D.
    Chem Biol Interact; 1982 Feb; 38(3):303-15. PubMed ID: 7037213
    [Abstract] [Full Text] [Related]

  • 7. Mutagenicity of potassium alkanediazotates and their use as model compounds for activated nitrosamines.
    Hecker LI, Saavedra JE, Farrelly JG, Andrews AW.
    Cancer Res; 1983 Sep; 43(9):4078-82. PubMed ID: 6347365
    [Abstract] [Full Text] [Related]

  • 8. Mutagenic potential of allyl and allylic compounds. Structure-activity relationship as determined by alkylating and direct in vitro mutagenic properties.
    Eder E, Neudecker T, Lutz D, Henschler D.
    Biochem Pharmacol; 1980 Apr 01; 29(7):993-8. PubMed ID: 6992786
    [No Abstract] [Full Text] [Related]

  • 9. Assay of 855 test chemicals in ten tester strains using a new modification of the Ames test for bacterial mutagens.
    McMahon RE, Cline JC, Thompson CZ.
    Cancer Res; 1979 Mar 01; 39(3):682-93. PubMed ID: 371791
    [Abstract] [Full Text] [Related]

  • 10. Unexpected genetic toxicity to rodents of the N',N'-dimethyl analogues of MNU and ENU.
    Tinwell H, Paton D, Guttenplan JB, Ashby J.
    Environ Mol Mutagen; 1996 Mar 01; 27(3):202-10. PubMed ID: 8625956
    [Abstract] [Full Text] [Related]

  • 11. Structure-activity relationships in the mutagenicity of N-substituted derivatives of phenanthrene-9,10-imine.
    Stark AA, Zeiger E, Shtelzer S, Sheradsky T, Lifshitz Y, Blum J.
    Mutagenesis; 1986 Jan 01; 1(1):35-9. PubMed ID: 3325734
    [Abstract] [Full Text] [Related]

  • 12. Mutagenic and alkylating activities of 3-methyl-1-phenyltriazenes and their possible role as carcinogenic metabolites of the parent dimethyl compounds.
    Malaveille C, Brun G, Kolar G, Bartsch H.
    Cancer Res; 1982 Apr 01; 42(4):1446-53. PubMed ID: 7060018
    [Abstract] [Full Text] [Related]

  • 13. Structure-activity relationship in halogen and alkyl substituted allyl and allylic compounds: correlation of alkylating and mutagenic properties.
    Neudecker T, Lutz D, Eder E, Henschler D.
    Biochem Pharmacol; 1980 Oct 01; 29(19):2611-7. PubMed ID: 7000076
    [No Abstract] [Full Text] [Related]

  • 14. Mutagenicity of carboline methyl derivatives in Salmonella.
    Rahden-Staroń I, Peczyńska-Czoch W, Kaczmarek L.
    Acta Microbiol Pol; 1994 Oct 01; 43(2):247-50. PubMed ID: 7530899
    [Abstract] [Full Text] [Related]

  • 15. The role of biotransformation in the genotoxicity of allylic compounds.
    Eder E, Dornbusch K, Fischer G.
    Arch Toxicol; 1987 Oct 01; 60(1-3):182-6. PubMed ID: 3619639
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.